News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
627,460 Results
Type
Article (38125)
Company Profile (122)
Press Release (589201)
Multimedia
Podcasts (104)
Webinars (11)
Section
Business (185090)
Career Advice (1875)
Deals (31449)
Drug Delivery (106)
Drug Development (70549)
Employer Resources (139)
FDA (15493)
Job Trends (13274)
News (310846)
Policy (30182)
Tag
Academia (2154)
Academic (2)
Accelerated approval (11)
Adcomms (17)
Allergies (100)
Alliances (48714)
ALS (102)
Alzheimer's disease (1282)
Antibody-drug conjugate (ADC) (139)
Approvals (15555)
Artificial intelligence (309)
Autoimmune disease (28)
Automation (22)
Bankruptcy (279)
Best Places to Work (10382)
BIOSECURE Act (17)
Biosimilars (125)
Biotechnology (80)
Bladder cancer (93)
Brain cancer (28)
Breast cancer (333)
Cancer (2715)
Cardiovascular disease (205)
Career advice (1603)
Career pathing (24)
CAR-T (182)
CDC (26)
Cell therapy (520)
Cervical cancer (26)
Clinical research (58441)
Collaboration (1065)
Company closure (2)
Compensation (434)
Complete response letters (26)
COVID-19 (2334)
CRISPR (59)
C-suite (339)
Cystic fibrosis (103)
Data (3003)
Decentralized trials (2)
Denatured (33)
Depression (59)
Diabetes (342)
Diagnostics (6187)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (34)
Drug discovery (144)
Drug pricing (116)
Drug shortages (31)
Duchenne muscular dystrophy (146)
Earnings (79275)
Editorial (41)
Employer branding (17)
Employer resources (120)
Events (94190)
Executive appointments (776)
FDA (17372)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (837)
Gene editing (123)
Generative AI (29)
Gene therapy (403)
GLP-1 (757)
Government (4088)
Grass and pollen (7)
Guidances (317)
Healthcare (15800)
HIV (39)
Huntington's disease (25)
IgA nephropathy (41)
Immunology and inflammation (131)
Immuno-oncology (11)
Indications (39)
Infectious disease (2497)
Inflammatory bowel disease (135)
Inflation Reduction Act (11)
Influenza (71)
Intellectual property (128)
Interviews (317)
IPO (14146)
IRA (43)
Job creations (3298)
Job search strategy (1356)
Kidney cancer (10)
Labor market (38)
Layoffs (421)
Leadership (22)
Legal (6998)
Liver cancer (69)
Longevity (9)
Lung cancer (382)
Lymphoma (203)
Machine learning (12)
Management (54)
Manufacturing (473)
MASH (89)
Medical device (12593)
Medtech (12604)
Mergers & acquisitions (18034)
Metabolic disorders (812)
Multiple sclerosis (86)
NASH (13)
Neurodegenerative disease (109)
Neuropsychiatric disorders (25)
Neuroscience (1913)
NextGen: Class of 2025 (5450)
Non-profit (3492)
Now hiring (28)
Obesity (388)
Opinion (234)
Ovarian cancer (81)
Pain (104)
Pancreatic cancer (118)
Parkinson's disease (165)
Partnered (18)
Patents (316)
Patient recruitment (167)
Peanut (48)
People (50209)
Pharmaceutical (38)
Pharmacy benefit managers (17)
Phase I (17917)
Phase II (25382)
Phase III (19818)
Pipeline (2135)
Policy (197)
Postmarket research (2311)
Preclinical (7697)
Press Release (71)
Prostate cancer (144)
Psychedelics (28)
Radiopharmaceuticals (235)
Rare diseases (439)
Real estate (5540)
Recruiting (52)
Regulatory (21683)
Reports (36)
Research institute (2000)
Resumes & cover letters (276)
Rett syndrome (9)
RNA editing (11)
RSV (46)
Schizophrenia (91)
Series A (143)
Series B (97)
Service/supplier (9)
Sickle cell disease (59)
Special edition (15)
Spinal muscular atrophy (136)
Sponsored (31)
Startups (3090)
State (1)
Stomach cancer (11)
Supply chain (80)
Tariffs (68)
The Weekly (70)
Vaccines (722)
Venture capital (40)
Weight loss (250)
Women's health (41)
Worklife (15)
Date
Today (104)
Last 7 days (487)
Last 30 days (2301)
Last 365 days (27633)
2025 (17498)
2024 (31181)
2023 (35755)
2022 (46455)
2021 (50504)
2020 (49107)
2019 (41467)
2018 (31251)
2017 (30516)
2016 (29548)
2015 (34450)
2014 (27414)
2013 (23610)
2012 (25058)
2011 (25414)
2010 (23272)
Location
Africa (743)
Alabama (60)
Alaska (6)
Arizona (180)
Arkansas (13)
Asia (38762)
Australia (6328)
California (6806)
Canada (2230)
China (700)
Colorado (314)
Connecticut (310)
Delaware (194)
Europe (84103)
Florida (1097)
Georgia (259)
Hawaii (2)
Idaho (50)
Illinois (616)
India (28)
Indiana (370)
Iowa (12)
Japan (237)
Kansas (101)
Kentucky (18)
Louisiana (13)
Maine (71)
Maryland (1008)
Massachusetts (5053)
Michigan (256)
Minnesota (375)
Mississippi (2)
Missouri (97)
Montana (27)
Nebraska (16)
Nevada (86)
New Hampshire (63)
New Jersey (2137)
New Mexico (26)
New York (1942)
North Carolina (1035)
North Dakota (9)
Northern California (3066)
Ohio (220)
Oklahoma (13)
Oregon (30)
Pennsylvania (1498)
Puerto Rico (15)
Rhode Island (34)
South America (1109)
South Carolina (39)
South Dakota (1)
Southern California (2601)
Tennessee (116)
Texas (1081)
United States (25934)
Utah (209)
Virginia (198)
Washington D.C. (60)
Washington State (574)
West Virginia (4)
Wisconsin (65)
627,460 Results for "spectrum chemicals and laboratory products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
August 8, 2025
·
3 min read
Press Releases
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
July 31, 2025
·
10 min read
Press Releases
Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides
July 21, 2025
·
7 min read
Press Releases
Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week
August 12, 2025
·
3 min read
Press Releases
Filgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 Study
July 28, 2025
·
9 min read
Press Releases
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
July 2, 2025
·
8 min read
Press Releases
There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate
July 2, 2025
·
10 min read
Press Releases
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
July 3, 2025
·
3 min read
Press Releases
Kodiak Sciences to Present at American Chemical Society Fall 2025
August 20, 2025
·
5 min read
Press Releases
Agendia Announces Publication in JNCI Cancer Spectrum Demonstrating that MammaPrint® Predicts Chemotherapy Benefit in HR+HER2- Early Breast Cancer Using Real-World Evidence from the FLEX Study
August 12, 2025
·
4 min read
1 of 62,746
Next
